Total synthesis of the O-antigen repeating unit of Providencia stuartii O49 serotype through linear and one-pot assemblies

• Tanmoy Halder and
• Somnath Yadav

Beilstein J. Org. Chem. 2021, 17, 2915–2921, doi:10.3762/bjoc.17.199

• was then deprotected and N-acetylated to finally afford the desired trisaccharide repeating unit as its α-p-methoxyphenyl glycoside. Keywords: capsular polysaccharide; carbohydrate vaccines; O-antigen; oligosaccharide synthesis; one-pot synthesis; Introduction O-antigens or O-specific

Progress and challenges in the synthesis of sequence controlled polysaccharides

• Giulio Fittolani,
• Theodore Tyrikos-Ergas,
• Denisa Vargová,
• Manishkumar A. Chaube and
• Martina Delbianco

Beilstein J. Org. Chem. 2021, 17, 1981–2025, doi:10.3762/bjoc.17.129

Synthesis of Streptococcus pneumoniae serotype 9V oligosaccharide antigens

• Sharavathi G. Parameswarappa,
• Claney L. Pereira and
• Peter H. Seeberger

Beilstein J. Org. Chem. 2020, 16, 1693–1699, doi:10.3762/bjoc.16.140

• Chemistry and Biochemistry, Arnimallee 22, 14195 Berlin, Germany 10.3762/bjoc.16.140 Abstract Streptococcus pneumoniae (SP) bacteria cause serious invasive diseases. SP bacteria are covered by a capsular polysaccharide (CPS) that is a virulence factor and the basis for SP polysaccharide and glycoconjugate

Synthetic avenues towards a tetrasaccharide related to Streptococcus pneumonia of serotype 6A

• Aritra Chaudhury,
• Mana Mohan Mukherjee and
• Rina Ghosh

Beilstein J. Org. Chem. 2018, 14, 1095–1102, doi:10.3762/bjoc.14.95

• antibodies elicited by SPn 6A would be effective against SPn 6B as well [10][11][12][13]. But recent studies have shown that serotype specific immune responses are elicited by the antibodies and that they cross react slowly [14]. As a result the importance of the presence of the capsular polysaccharide of

Preactivation-based chemoselective glycosylations: A powerful strategy for oligosaccharide assembly

• Weizhun Yang,
• Bo Yang,
• Sherif Ramadan and
• Xuefei Huang

Beilstein J. Org. Chem. 2017, 13, 2094–2114, doi:10.3762/bjoc.13.207

• glycolipid family including LewisX pentasaccharide 117, dimeric LewisX 118 [63], tristearoyl lipomannan 119 [64], gangliosides GM1 120 [65] and GM2 121 (Figure 5) [66], microbial glycans such as the heptasaccharide repeating unit of type V group B Streptococcus capsular polysaccharide 122 [67], β-glucan

Glyco-gold nanoparticles: synthesis and applications

• Federica Compostella,
• Olimpia Pitirollo,
• Alessandro Silvestri and
• Laura Polito

Beilstein J. Org. Chem. 2017, 13, 1008–1021, doi:10.3762/bjoc.13.100

• - and disaccharides related to the capsular polysaccharide of serogroup A of Neisseria meningitides [53]. The results showed that the systems were able to activate the antigen-presenting cells, to induce the releasing of effector functions of the same cells and to stimulate T cell proliferation, but

Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide

• Peter H. Seeberger,
• Claney L. Pereira and
• Subramanian Govindan

Beilstein J. Org. Chem. 2017, 13, 164–173, doi:10.3762/bjoc.13.19

• Deutschland GmbH, Magnusstrasse 11, 12489 Berlin, Germany 10.3762/bjoc.13.19 Abstract The Gram-positive bacterium Streptococcus pneumoniae causes severe disease globally. Vaccines that prevent S. pneumoniae infections induce antibodies against epitopes within the bacterial capsular polysaccharide (CPS). A

• a mixture of AcOH/H2O/t-BuOH prior to ester hydrolysis using LiOH/H2O2 enabled the hexasaccharide 1 to be obtained in 37% yield (Scheme 9). Conclusion The first total synthesis of the S. pneumoniae serotype 12F capsular polysaccharide repeating unit hexasaccharide 1 was achieved by means of a linear

• immunological analysis of S. pneumoniae serotype 12F can be undertaken, and future work will address the expanded inclusion of this antigen in next-generation glycoconjugate vaccines. Abbreviations Ac: acetate ester; BAIB: bis(acetoxy)iodobenzene; Bz: benzoyl; CPS: capsular polysaccharide; DMF: N,N

Automated glycan assembly of a S. pneumoniae serotype 3 CPS antigen

• Markus W. Weishaupt,
• Stefan Matthies,
• Mattan Hurevich,
• Claney L. Pereira,
• Heung Sik Hahm and
• Peter H. Seeberger

Beilstein J. Org. Chem. 2016, 12, 1440–1446, doi:10.3762/bjoc.12.139

• Berlin, Arnimallee 22, 14195 Berlin, Germany 10.3762/bjoc.12.139 Abstract Vaccines against S. pneumoniae, one of the most prevalent bacterial infections causing severe disease, rely on isolated capsular polysaccharide (CPS) that are conjugated to proteins. Such isolates contain a heterogeneous

• -preventable deaths in children under five years worldwide [5]. Over 90 different serotypes of S. pneumoniae have been identified, each of which expresses a unique capsular polysaccharide (CPS) [6][7][8][9]. The S. pneumoniae serotype 3 CPS was first isolated in 1924 [10] and its exact chemical structure was

Elucidation of a masked repeating structure of the O-specific polysaccharide of the halotolerant soil bacteria Azospirillum halopraeferens Au4

• Elena N. Sigida,
• Yuliya P. Fedonenko,
• Alexander S. Shashkov,
• Nikolay P. Arbatsky,
• Evelina L. Zdorovenko,
• Svetlana A. Konnova,
• Vladimir V. Ignatov and
• Yuriy A. Knirel

Beilstein J. Org. Chem. 2016, 12, 636–642, doi:10.3762/bjoc.12.62

• chain (OPS) called O antigen and capsular polysaccharide (K antigen) of Azospirillum, which is an extracellular form of LPS [8][9], are important for the interaction between bacteria and host plants. The cell-surface polysaccharides of Azospirillum are involved in overcoming of unfavorable conditions

Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments

• Laura Morelli,
• Damiano Cancogni,
• Marta Tontini,
• Alberto Nilo,
• Sara Filippini,
• Paolo Costantino,
• Maria Rosaria Romano,
• Francesco Berti,
• Roberto Adamo and
• Luigi Lay

Beilstein J. Org. Chem. 2014, 10, 2367–2376, doi:10.3762/bjoc.10.247

• , 53100 Siena, Italy 10.3762/bjoc.10.247 Abstract A vaccine to prevent infections from the emerging Neisseria meningitidis X (MenX) is becoming an urgent issue. Recently MenX capsular polysaccharide (CPS) fragments conjugated to CRM197 as carrier protein have been confirmed at preclinical stage as

• meningitis epidemics have been recorded in Africa, in an area termed “the meningitis belt”, extending from Senegal to Ethiopia and including 21 countries with a population of over 300 million people. According to the chemical composition of the bacterial capsular polysaccharide (CPS) [1], 13 serogroups of N

Synthesis of 6-PEtN-α-D-GalpNAc-(1–>6)-β-D-Galp-(1–>4)-β-D-GlcpNAc-(1–>3)-β-D-Galp-(1–>4)-β-D-Glcp, a Haemophilus influenzae lipopolysacharide structure, and biotin and protein conjugates thereof

• Andreas Sundgren,
• Martina Lahmann and
• Stefan Oscarson

Beilstein J. Org. Chem. 2010, 6, 704–708, doi:10.3762/bjoc.6.80

• six serotypes, a–f, related to the structure of the capsular polysaccharide usually surrounding the bacterium [1]. Among these serotypes, type b is the cause of the most severe diseases, i.a. meningitis and pneumonia. However, there are now several commercial vaccines against this serotype that have